STAT3 was found to increase the expression of BCL6 in breast cancer cells; however, the STAT5-mediated repression of BCL6 in these cells was dominant, because STAT5 displaced STAT3 from the shared DNA-binding site [13] (Fig. 3). The gene discussed is STAT3; the disease is breast carcinoma.